BIOMARKER-DRIVEN AND PRECISION THERAPY

IMMUNOTHERAPY AND NOVEL COMBINATIONS

HPV-ASSOCIATED AND HPV-NEGATIVE HEAD AND NECK CANCERS

EMERGING ANTIBODY–DRUG CONJUGATES, BISPECIFIC ANTIBODIES, AND CELLULAR THERAPIES 

LOCALLY ADVANCED, RECURRENT, AND METASTATIC DISEASE

ORAL CAVITY, OROPHARYNGEAL, LARYNGEAL, HYPOPHARYNGEAL, NASOPHARYNGEAL, AND SALIVARY GLAND CANCERS